By Counterforce Health Team in Waylivra (volanesorsen) —

How to Get Waylivra (Volanesorsen) Covered by Cigna in Georgia: Appeals, Forms, and State Protections

Answer Box: Getting Waylivra (Volanesorsen) Covered by Cigna in Georgia

Waylivra (volanesorsen) is not FDA-approved or on Cigna's formulary, requiring a medical necessity exception with comprehensive FCS documentation. Your fastest path: (1) Have your lipid specialist submit genetic FCS confirmation, triglycerides ≥885 mg/dL, and prior therapy failures via Cigna's formulary exception process, (2) If denied, file an internal appeal within 180 days, then (3) Request Georgia external review within 60 days of final denial through the Georgia Department of Insurance at 1-800-656-2298. Georgia external review is free and binding on insurers.

Table of Contents

  1. What Drives Waylivra Coverage Challenges
  2. Benefit Investigation: What to Ask Cigna
  3. Manufacturer and Foundation Assistance
  4. Filing a Formulary Exception Request
  5. Specialty Pharmacy Coordination
  6. Appeals Process: Internal and External
  7. Annual Renewal Considerations
  8. Conversation Scripts

What Drives Waylivra Coverage Challenges

Waylivra (volanesorsen) faces unique coverage barriers that directly impact your out-of-pocket costs. Understanding these challenges helps you build a stronger case for approval.

Primary Coverage Obstacles:

  • Non-formulary status: Waylivra is not on Cigna's 2024 formulary, including Express Scripts-managed plans
  • Lack of FDA approval: The drug was rejected by FDA for familial chylomicronemia syndrome (FCS), though it's approved in the EU
  • Specialty tier pricing: When considered, it would fall into Tier 4/5 with highest cost-sharing
  • Complex administration: Weekly subcutaneous injections requiring intensive platelet monitoring
Note: Even with approval, expect significant cost-sharing. Cigna typically requires 20-50% coinsurance for specialty drugs, with no copay cap for non-formulary medications.

Benefit Investigation: What to Ask Cigna

Before pursuing coverage, gather specific information about your plan's policies and your potential costs.

Essential Questions for Cigna Member Services:

  1. "Is Waylivra (volanesorsen) on my plan's formulary, and what tier is it?"
    • Record the representative's name and reference number
    • Ask for written confirmation via member portal
  2. "What's my specialty drug cost-sharing for non-formulary medications?"
    • Get your annual deductible, coinsurance percentage, and out-of-pocket maximum
    • Confirm whether specialty drugs count toward your deductible
  3. "How do I request a formulary exception for a non-FDA approved drug?"
  4. "What documentation is required for medical necessity?"
    • Request their clinical criteria for FCS treatments
    • Ask about genetic testing requirements

Information to Record:

  • Plan type (HMO, PPO, EPO) and group number
  • Specialty pharmacy network (typically Accredo for Cigna)
  • Prior authorization requirements and timelines
  • Appeal deadlines and processes

Manufacturer and Foundation Assistance

Unfortunately, no active U.S. manufacturer copay assistance program exists for Waylivra since it's not commercially marketed here. However, alternative support options may be available.

Potential Assistance Sources:

Compassionate Use Programs:

  • Contact Ionis Medical Information directly to inquire about expanded access
  • Requires physician request and documented severe, uncontrolled FCS
  • Typically reserved for patients with no reasonable alternatives

Foundation Support:

State-Specific Resources:

  • Georgia has limited Medicaid expansion, so most residents rely on private insurance
  • Georgians for a Healthy Future provides consumer assistance with appeals
From our advocates: "We've seen patients successfully access non-FDA approved medications through persistent appeals combined with foundation grants covering the cost-sharing portion. The key is demonstrating that all FDA-approved alternatives have failed or are contraindicated."

Filing a Formulary Exception Request

Since Waylivra is non-formulary, you'll need a medical necessity exception rather than standard prior authorization.

Step-by-Step: Fastest Path to Approval

  1. Specialist Preparation (Your lipid specialist does this)
    • Gather genetic FCS confirmation or NAFCS score ≥60
    • Document fasting triglycerides ≥885 mg/dL on multiple occasions
    • Record all prior therapy failures (fibrates, omega-3s, diet modifications)
  2. Submit Exception Request (1-2 business days)
    • Use Cigna's formulary exception form (verify current version)
    • Include ICD-10 code E78.3 (familial chylomicronemia syndrome)
    • Submit via Cigna provider portal or fax
  3. Initial Review (72 hours standard, 24 hours expedited)
    • Cigna reviews against medical necessity criteria
    • May request additional documentation or peer-to-peer review
  4. Accredo Coordination (If approved)
    • Enrollment form faxed to 888.302.1028
    • Specialty pharmacy handles delivery and monitoring coordination

Medical Necessity Documentation Checklist

Required Clinical Evidence:

  • ✓ Confirmed FCS diagnosis (genetic testing or validated clinical score)
  • ✓ Persistent fasting triglycerides ≥885 mg/dL (multiple measurements)
  • ✓ History of recurrent pancreatitis or severe symptoms
  • ✓ Documentation of failed standard therapies
  • ✓ Platelet monitoring plan (weekly initially, then every 2 weeks)
  • ✓ Contraindications to FDA-approved alternatives like Tryngolza

Supporting Literature:

  • EMA approval documentation for international use
  • Peer-reviewed studies on volanesorsen efficacy in FCS
  • Clinical guidelines supporting antisense oligonucleotide therapy

Specialty Pharmacy Coordination

Waylivra requires specialty pharmacy dispensing through Cigna's network, typically Accredo, due to its complex storage and monitoring requirements.

Accredo Coordination Benefits:

  • Refrigerated storage and delivery (2-8°C requirement)
  • Patient training for subcutaneous self-injection
  • Platelet monitoring reminders and coordination
  • Prior authorization management and appeals support

Key Coordination Steps:

  1. Enrollment: Prescriber completes Accredo enrollment form
  2. Training: Nurse educator provides injection training
  3. Monitoring Setup: Weekly platelet counts initially, adjusting based on response
  4. Delivery: Temperature-controlled shipping to patient's address
Tip: Accredo can often expedite the prior authorization process and provide additional clinical support for complex cases like Waylivra.

Appeals Process: Internal and External

If your initial formulary exception is denied, Georgia provides strong consumer protections through a two-level appeals process.

Internal Appeals with Cigna

Timeline: File within 180 days of denial Decision: 30 days for standard, 72 hours for expedited Who can file: You, your prescriber, or authorized representative

Required Documentation:

  • Copy of original denial letter
  • Updated medical necessity letter addressing denial reasons
  • Any new clinical evidence or test results
  • Request for peer-to-peer review if not already conducted

Georgia External Review Process

Georgia's external review is particularly powerful - it's conducted by independent physicians and is binding on Cigna.

Key Details:

  • Deadline: 60 days from Cigna's final internal denial
  • Cost: Free to consumers
  • Timeline: 30 business days (72 hours if expedited)
  • Scope: Covers "not medically necessary" and experimental/investigational denials

How to File:

  1. Contact Georgia DOI: Call 1-800-656-2298 or use online complaint form
  2. Submit Application: Download external review form (verify current link)
  3. Provide Documentation: Include all denial letters, medical records, and supporting evidence
  4. Independent Review: Specialists in the same field review your case
  5. Final Decision: Georgia DOI issues binding decision letter
Important: Georgia allows concurrent external review with expedited internal appeals if your medical situation is urgent, meaning you don't have to wait for internal appeals to complete.

Common Denial Reasons & Fixes

Denial Reason How to Overturn Documentation Needed
"Not FDA-approved" Emphasize EU approval, compassionate use precedent EMA approval documents, international guidelines
"Experimental/investigational" Cite established use in Europe, published efficacy data Peer-reviewed studies, real-world evidence
"Not medically necessary" Document FCS severity, prior failures Genetic testing, triglyceride trends, pancreatitis history
"Alternatives available" Prove contraindications or failures with FDA-approved options Trial documentation, adverse event reports

Annual Renewal Considerations

What Can Change:

  • Formulary status (rare but possible if FDA approval occurs)
  • Cost-sharing tiers and percentages
  • Prior authorization requirements
  • Specialty pharmacy network

Renewal Preparation:

  • Request updated prior authorization 60 days before current approval expires
  • Update clinical documentation with recent labs and response data
  • Confirm continued FCS diagnosis and treatment necessity
  • Review any new treatment options that may have become available

Conversation Scripts

Calling Cigna Member Services

"Hi, I need information about coverage for Waylivra, spelled W-A-Y-L-I-V-R-A, generic name volanesorsen, for familial chylomicronemia syndrome. Can you tell me if this is on my formulary and what the prior authorization process is? I also need to know my specialty drug cost-sharing and whether you have specific clinical criteria for FCS treatments."

Requesting Peer-to-Peer Review

"I'm requesting a peer-to-peer review for the denied prior authorization [reference number]. This is for Waylivra for confirmed familial chylomicronemia syndrome. I have genetic confirmation, documented treatment failures, and this patient has a history of recurrent pancreatitis. Can we schedule a call with a lipid specialist or endocrinologist on your medical team?"

Escalating to Georgia DOI

"I need to file an external review request for a denied medication coverage. My insurer denied coverage for a medically necessary treatment for familial chylomicronemia syndrome, and I've exhausted internal appeals. Can you walk me through the external review process and send me the required forms?"

Getting specialized help with Waylivra appeals can make the difference between approval and denial. Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned to each insurer's specific rules, pulling the right clinical evidence and citations to support complex cases like non-FDA approved medications for rare diseases.

Whether you're navigating Cigna's formulary exception process or preparing for Georgia's external review, having the right documentation and clinical support significantly improves your chances of success. Remember that persistence often pays off - many initial denials are overturned on appeal when proper evidence is provided.

Sources & Further Reading

This guide is for informational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For additional help with insurance appeals in Georgia, contact the Georgia Department of Insurance Consumer Services at 1-800-656-2298.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.